Pintarnya | $16,700,000 | (Aug 26, 2025)
Barti | $12,000,000 | (Aug 26, 2025)
Soil Action, Inc. | $5,250,000 | (Aug 26, 2025)
Certified by Founder
Lodge
CinCor Pharma, Inc.
start up
United States
- Boston, MA
- 12/10/2021
- Series B
- $143,000,000
DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIOVASCULAR DISEASES.
- Industry Biotechnology Research
- Website https://www.cincor.com/
- LinkedIn https://www.linkedin.com/company/cincor/
Irys | $10,000,000 | (Aug 26, 2025)
Arintra | $21,000,000 | (Aug 26, 2025)
Oway | $4,000,000 | (Aug 26, 2025)
Paragraf | $55,000,000 | (Aug 26, 2025)
Genow | $1,921,342 | (Aug 26, 2025)
Luna Diabetes | $23,600,000 | (Aug 26, 2025)
Dirac, Inc. | $10,700,000 | (Aug 26, 2025)
STARK | $62,000,000 | (Aug 26, 2025)
Incyclix Bio | $11,250,000 | (Aug 26, 2025)